Insider · CIK 0001748622
Elizabeth Bhatt
Files at EFTR (eFFECTOR Therapeutics, Inc.), SEPN (Septerna, Inc.). First filing Feb 20, 2026, latest Aug 13, 2026.
In brief
Elizabeth Bhatt files SEC Form 4 as COO, president and director at SEPN (Septerna, Inc.), and also at EFTR (eFFECTOR Therapeutics, Inc.). Since Feb 20, 2026, Elizabeth Bhatt has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.4M, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Elizabeth Bhatt has 0, so none is measured yet.
The newest scored trade: sold $1.1M of SEPN on Aug 11, 2026, filed Aug 13, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $1.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SEPN: Septerna, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Septerna, Inc. | $1.1M 25,000 shares | -13% | +337% from low0% from high | |
| 4Weak | Septerna, Inc. | $136k 4,000 shares | -2% | +212% from low-10% from high | |
| 0Weak | Septerna, Inc. | $97k 4,000 shares | -2% | +342% from low-16% from high | |
| 3Weak | Septerna, Inc. | $116k 4,000 shares | -2% | +464% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 11, 2026 | SEPN Septerna, Inc. | 29,000 0.06% of outstanding | $1.1M | Aug 11, 2026 | $136k |
| Jul 15, 2026 | SEPN Septerna, Inc. | 4,000 0.01% of outstanding | $138k | Jul 15, 2026 | none |
| Feb 18, 2026 | SEPN Septerna, Inc. | 8,000 0.02% of outstanding | $242k | Feb 18, 2026 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | SEPN Septerna, Inc. | MOption exercise Common Stock10b5-1 | +18,681 | $6.81 | $127k | 192,890 | Aug 13, 2026 |
| Aug 11, 2026 | SEPN Septerna, Inc. | MOption exercise Common Stock10b5-1 | +6,319 | $2.76 | $17k | 199,209 | Aug 13, 2026 |
| Aug 11, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $44.00 | $1.1M | 174,209 | Aug 13, 2026 |
| Aug 11, 2026 | SEPN Septerna, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,681 | $0.00 | $0 | 62,230 | Aug 13, 2026 |
| Aug 11, 2026 | SEPN Septerna, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,319 | $0.00 | $0 | 82,332 | Aug 13, 2026 |
| Jul 15, 2026 | SEPN Septerna, Inc. | MOption exercise Common Stock10b5-1 | +4,000 | $6.81 | $27k | 178,209 | Jul 17, 2026 |
| Jul 15, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -4,000 | $33.99 | $136k | 174,209 | Jul 17, 2026 |
| Jul 15, 2026 | SEPN Septerna, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,000 | $0.00 | $0 | 80,911 | Jul 17, 2026 |
| Apr 15, 2026 | SEPN Septerna, Inc. | MOption exercise Common Stock10b5-1 | +4,000 | $6.81 | $27k | 178,209 | Apr 17, 2026 |
| Apr 15, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -2,573 | $23.76 | $61k | 175,636 | Apr 17, 2026 |
| Apr 15, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -1,101 | $25.24 | $28k | 174,535 | Apr 17, 2026 |
| Apr 15, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -326 | $25.86 | $8,431 | 174,209 | Apr 17, 2026 |
| Apr 15, 2026 | SEPN Septerna, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,000 | $0.00 | $0 | 84,911 | Apr 17, 2026 |
| Feb 18, 2026 | SEPN Septerna, Inc. | MOption exercise Common Stock10b5-1 | +4,000 | $6.81 | $27k | 178,209 | Feb 20, 2026 |
| Feb 18, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -2,200 | $28.46 | $63k | 176,009 | Feb 20, 2026 |
| Feb 18, 2026 | SEPN Septerna, Inc. | SOpen-market sale Common Stock10b5-1 | -1,800 | $29.58 | $53k | 174,209 | Feb 20, 2026 |
| Feb 18, 2026 | SEPN Septerna, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,000 | $0.00 | $0 | 88,911 | Feb 20, 2026 |
| Feb 6, 2026 | SEPN Septerna, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +155,000 | $0.00 | $0 | 155,000 | Feb 10, 2026 |
| Aug 7, 2025 | SEPN Septerna, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +95,000 | $0.00 | $0 | 95,000 | Aug 11, 2025 |
| Feb 19, 2024 | EFTR eFFECTOR Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,000 | $0.00 | $0 | 2,000 | Feb 21, 2024 |
Questions about Elizabeth Bhatt
Answered from the filings on this page, as of the latest one.
Is Elizabeth Bhatt buying or selling?
In the last 12 months Elizabeth Bhatt reported 0 open-market buys worth $0 and 4 open-market sells worth $1.4M on SEC Form 4; the latest was sold $1.1M of SEPN on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Elizabeth Bhatt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elizabeth Bhatt has 0.
Where does Elizabeth Bhatt file Form 4?
Elizabeth Bhatt has filed Form 4 at SEPN (Septerna, Inc.) as President and COO; EFTR (eFFECTOR Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.